en
Scientific article
Review
English

The role of cisapride in the treatment of pediatric gastroesophageal reflux. The European Society of Paediatric Gastroenterology, Hepatology and Nutrition

Published inJournal of pediatric gastroenterology and nutrition, vol. 28, no. 5, p. 518-528
Publication date1999
Abstract

Cisapride is a gastrointestinal prokinetic agent that is used worldwide in the treatment of gastrointestinal motility-related disorders in premature infants, full-term infants, and children. Efficacy data suggest that it is the most effective commercially available prokinetic drug.

Keywords
  • Arrhythmias, Cardiac/chemically induced
  • Cisapride/administration & dosage/adverse effects/therapeutic use
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 Enzyme System/metabolism
  • Drug Interactions
  • Gastroesophageal Reflux/drug therapy
  • Gastrointestinal Agents/administration & dosage/adverse effects/therapeutic use
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Mixed Function Oxygenases/metabolism
  • Risk Factors
Citation (ISO format)
VANDENPLAS, Y et al. The role of cisapride in the treatment of pediatric gastroesophageal reflux. The European Society of Paediatric Gastroenterology, Hepatology and Nutrition. In: Journal of pediatric gastroenterology and nutrition, 1999, vol. 28, n° 5, p. 518–528.
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0277-2116
420views
0downloads

Technical informations

Creation06/29/2015 3:49:00 PM
First validation06/29/2015 3:49:00 PM
Update time03/14/2023 11:26:24 PM
Status update03/14/2023 11:26:24 PM
Last indexation01/16/2024 6:28:30 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack